Health Policy
WHO guidelines, EU directives, and Georgian health governance
Biotech Industry Faces Political Uncertainty and AI Profitability Questions at BIO 2026
Biotech executives at BIO 2026 confronted mounting concerns over Chinese competition, the uncertain profitability of AI-driven drug discovery, and political…
Editor's Top Picks
Eli Lilly’s Obesity Drug Access: What We Know About FDA Approval Pathways
Regulatory pathways and corporate strategy shape early access to obesity drug candidates. Pharmaceutical acquisitions in the metabolic disease sector reflect…
Submit Your Paper →
More form Health Policy
English Resident Doctors Plan Four-Day Strike in June Over Stalled Pay Negotiations
Resident doctors in England will stage their 16th walkout from 15-19 June after talks collapsed…
Abortion Drug Restrictions Threaten Emergency Obstetric Care, Medical Experts Warn
New state laws classifying abortion medications as controlled substances are creating barriers to emergency obstetric…
UK Screening Committee Sets Evidence Standards for Multicancer Detection Tests
UK National Screening Committee publishes first formal evidence requirements for multicancer detection tests, setting rigorous…
WOAH Calls for Standardised Trade Rules as Countries Deploy HPAI Vaccination Strategies
WOAH issues new guidance for harmonised international trade standards as 40+ countries adopt HPAI vaccination…
Eight Former CDC Directors Warn Against Dismantling PEPFAR Program
Eight former CDC directors warn against State Department plans to restructure PEPFAR, arguing the changes…